We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





New 1-Minute COVID-19 Antibody Test Uses Innovative Flow-Through Technology to Deliver Results

By LabMedica International staff writers
Posted on 16 Oct 2020
A new one-minute antibody test for COVID-19 launched in Europe is the only test of its kind to use innovative flow-through technology to deliver results, making it far faster than other antibody tests currently available.

bioLytical Laboratories (Vancouver, BC, Canada) has launched INSTI COVID-19 Antibody Test, its new one-minute test that detects antibodies to SARS-CoV-2 with high accuracy, in Europe following the notification of CE mark and approval to sell the test across the region. More...
The test detects total antibodies to SARS-CoV-2 and is the only one of its kind to use innovative flow-through technology to deliver results, making it far faster than other antibody tests currently available. The INSTI COVID-19 Antibody Test is completely portable, does not require additional equipment and can be performed in a multitude of settings with easy-to-interpret results. Test providers have the advantage of running more tests in less time, due to INSTI's market-leading speed.

“Reliable and truly rapid antibody tests are an important part of our response to this global crisis,” said Robert Mackie, Chief Executive Officer. “The INSTI COVID-19 Antibody Test is a uniquely effective tool and distribution of our one-minute test kits around the globe is a critical step for tackling the spread of this virus.”

Related Links:
bioLytical Laboratories


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.